To conduct outstanding biomedical research to enhance the quality of life, medical care, and societal integration of patients suffering from ME/CFS.
We stand as a patient-focused community, dedicated to advancing biomedical understanding of ME/CFS with the goal to deliver diagnosis and treatment solutions for its patients, and, where possible, for related conditions.
We do this through the creation of a diverse and multidisciplinary national research network, integrated within the global research community. We are committed to the long-term viability of this community and its mission through knowledge dissemination, stakeholder engagement and ensuring financial stability.
The core stakeholders (patients, clinicians and researchers) are involved in all decision-making processes through co-creation.
The way of working is always collaborative, adhering to the principles of open science and FAIR data. Hereby, we foster innovative exchanges across disciplines, fuelling the consortium’s progress.
We are committed to patient-centred, high-quality biomedical research.
